Compare Davita Inc (DVA) vs Manchester United PLC (MANU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Davita Inc vs Manchester United PLC — how do they compare? Davita Inc trades at $179.02 (market cap $11.72B), while Manchester United PLC trades at $22.23 (market cap $3.74B). The key difference: Davita Inc is far larger — about 3.1× Manchester United PLC's market cap, and Manchester United PLC pays a 1.26% dividend while Davita Inc pays none. Which is the better fit depends on your goals.
| DVA | MANU | |
|---|---|---|
Market Cap | $11.72B | $3.74B |
Sector | Health | Media |
52-Week High | $240.96 | $23.53 |
52-Week Low | $103.87 | $15.10 |
Enterprise Value | $24.44B | $4.68B |
Dividend Yield | — | 1.26% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $183.77, up 1.72% today, with a mixed technical picture showing bearish moving averages but bullish oscillators. The company reported strong Q2 2026 earnings of $4.02 per share, beating estimates, driven by volume growth. Revenue reached $13.64 billion in 2025, with a net income margin of 6.05%. Analyst consensus is a Buy with a $232.25 price target, though technical signals are bearish overall.
The outlook for DVA is cautiously optimistic, supported by earnings beats and volume growth, but risks include reimbursement pressure and high debt levels. The stock offers potential upside to the consensus target, yet investors face headwinds from margin compression and technical bearishness.
Manchester United (MANU) trades at $21.63, down 1.28% on the day, with a bearish technical signal and negative profitability metrics including a net income margin of -2.65% and ROE of -6.36%. Recent news highlights stadium development progress and Champions League qualification, but revenue growth remains limited. Cash flow trends show volatile investing activities, with 2025 net cash flow at $12.56 million.
The outlook is mixed: analyst consensus leans Hold (60%) with potential from cost reductions and stadium plans, but persistent losses and high debt pose risks. Near-term catalysts include Q2 2026 earnings, yet structural challenges in revenue expansion and weak cash conversion temper upside potential for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →About Manchester United PLC
Manchester United PLC operates a professional football club together with related and ancillary activities. The company manages the soccer team and all affiliated club activities of the Manchester United Football Club, which includes the media network, foundation, fan zone, news, sports features, and team merchandise. Manchester United is based in England. The company has three principal sectors from which most of the revenue is generated, including Commercial, Broadcasting, and Matchday.
Read more on MANU →
